KCNN4 and neoplasm: miR-497-5p was also found to target and repress the calcium-activated potassium channel KCa3.1, such that the use of a KCa3.1 inhibitor or miR-497-5p mimics in an in vivo angiosarcoma xenograft inhibited tumour growth [102].